Hengrui Pharma Declares FY2025 Final Dividend of RMB 0.20 per Share

Bulletin Express03-26

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has announced a final ordinary dividend of RMB 2 for every 10 shares (equivalent to RMB 0.20 per share) for the financial year ended 31 December 2025.

Shareholders will vote on the proposal at the annual general meeting scheduled for 16 April 2026.

Key timetable items—including ex-dividend date, record date, and payment date—will be released once the Hong Kong share register confirms the default currency, applicable exchange rate, and related administrative details.

The company stated that, should its total share capital change before the record date, the distribution ratio of RMB 0.20 per share will remain unchanged; the aggregate payout will be adjusted in line with the revised share count.

Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, will serve as the Hong Kong share registrar for the dividend distribution.

No information on withholding tax or listed warrants/convertible securities accompanied the dividend announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1120770095?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 06:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120770095","market":"us","top_or_hot":-1,"title":"Hengrui Pharma Declares FY2025 Final Dividend of RMB 0.20 per Share","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has announced a final ordinary dividend of RMB 2 for every 10 shares (equivalent to RMB 0.20 per share) for the financial year ended 31 December 2025.</p>\n<p>Shareholders will vote on the proposal at the annual general meeting scheduled for 16 April 2026.</p>\n<p>Key timetable items—including ex-dividend date, record date, and payment date—will be released once the Hong Kong share register confirms the default currency, applicable exchange rate, and related administrative details.</p>\n<p>The company stated that, should its total share capital change before the record date, the distribution ratio of RMB 0.20 per share will remain unchanged; the aggregate payout will be adjusted in line with the revised share count.</p>\n<p>Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, will serve as the Hong Kong share registrar for the dividend distribution.</p>\n<p>No information on withholding tax or listed warrants/convertible securities accompanied the dividend announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma Declares FY2025 Final Dividend of RMB 0.20 per Share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma Declares FY2025 Final Dividend of RMB 0.20 per Share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-26 06:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has announced a final ordinary dividend of RMB 2 for every 10 shares (equivalent to RMB 0.20 per share) for the financial year ended 31 December 2025.</p>\n<p>Shareholders will vote on the proposal at the annual general meeting scheduled for 16 April 2026.</p>\n<p>Key timetable items—including ex-dividend date, record date, and payment date—will be released once the Hong Kong share register confirms the default currency, applicable exchange rate, and related administrative details.</p>\n<p>The company stated that, should its total share capital change before the record date, the distribution ratio of RMB 0.20 per share will remain unchanged; the aggregate payout will be adjusted in line with the revised share count.</p>\n<p>Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, will serve as the Hong Kong share registrar for the dividend distribution.</p>\n<p>No information on withholding tax or listed warrants/convertible securities accompanied the dividend announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1120770095","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120770095","pubTimestamp":1774478482,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has announced a final ordinary dividend of RMB 2 for every 10 shares (equivalent to RMB 0.20 per share) for the financial year ended 31...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药宣派2025财年末期股息每股人民币0.20元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has announced a final ordinary dividend of RMB 2 for every 10 shares (equivalent to RMB 0.20 per share) for the financial year ended 31 December 2025.\nShareholders will vote on the proposal at the annual general meeting scheduled for 16 April 2026.\nKey timetable items—including ex-dividend date, record date, and payment date—will be released once the Hong Kong share register confirms the default currency, applicable exchange rate, and related administrative details.\nThe company stated that, should its total share capital change before the record date, the distribution ratio of RMB 0.20 per share will remain unchanged; the aggregate payout will be adjusted in line with the revised share count.\nTricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, will serve as the Hong Kong share registrar for the dividend distribution.\nNo information on withholding tax or listed warrants/convertible securities accompanied the dividend announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120770095","isCrawlerRequest":true}